Compare PZZA & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PZZA | PLSE |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 1995 | 2015 |
| Metric | PZZA | PLSE |
|---|---|---|
| Price | $33.39 | $25.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $45.00 | $22.00 |
| AVG Volume (30 Days) | ★ 1.1M | 344.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $2,068,421,000.00 | N/A |
| Revenue This Year | N/A | $840.00 |
| Revenue Next Year | N/A | $287.54 |
| P/E Ratio | $155.88 | ★ N/A |
| Revenue Growth | ★ 14.07 | N/A |
| 52 Week Low | $30.16 | $12.56 |
| 52 Week High | $55.74 | $27.98 |
| Indicator | PZZA | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 60.27 |
| Support Level | $33.30 | $17.58 |
| Resistance Level | $35.49 | $27.14 |
| Average True Range (ATR) | 1.80 | 1.86 |
| MACD | -0.08 | 0.45 |
| Stochastic Oscillator | 50.64 | 76.82 |
Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.